Weight Loss Drug Helps Treat Sleep Apnea - eFitnessNow


dBTechno

Weight Loss Drug Helps Treat Sleep Apnea
eFitnessNow
A small, mid-stage trial of Qnexa an experimental weight-loss drug, was shown to lower sleep apnea, by 69% in a mid-stage trial. The study involved 45 obese ...
Vivus drug cuts apnea in small trial; shares jumpReuters

Mid Stage Trial of Qnexa Shows Reduction in ApneaTopNews United States
Vivus Obesity Drug Shows Effectiveness In Sleep ApneaWall Street Journal
Shift Work Disorder News -BusinessWeek -PR Newswire (press release)
all 143 news articles »

Similar Weight Loss Posts

  • Vivus’ Qnexa improves sleep apnea in small trial - Reuters
    Vivus' Qnexa improves sleep apnea in small trialReutersQnexa-treated patients lost 10.2 percent of their body weight, compared with weight loss of 4.3 percent for placebo patients. ...VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive ...PR Newswire


  • Vivus drug cuts apnea in small trial; shares jump - Reuters
    dBTechnoVivus drug cuts apnea in small trial; shares jumpReutersQnexa-treated patients lost 10.2 percent of their body weight, compared with weight loss of 4.3 percent for placebo patients. ...Can An Obesity Drug Treat Sleep Apnea?Forbes (blog)Vivus drug cuts apnea in small


  • VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control … - PR Newswire (press release)
    VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control ...PR Newswire (press release), NYThe study demonstrated that Qnexa, an investigational new drug, significantly reduced patients' hemoglobin A1c (HbA1c) -- a key indicator of blood sugar control -- and helped patients achieve and


  • Race for Obesity Drugs Heats Up - Wall Street Journal
    TopNews United StatesRace for Obesity Drugs Heats UpWall Street JournalArena Pharmaceuticals Inc. on Friday reported a successful late-stage trial of its weight-loss drug, but Vivus Inc. is still considered the ...Arena's Lorcaserin Has Safety EdgeSeeking Alpha (blog)Back to the StairMaster,


  • US Advisory Committee to Re-evaluate Vivus’s Weight Loss Drug in July - TopNews United States
    TopNews United StatesUS Advisory Committee to Re-evaluate Vivus's Weight Loss Drug in JulyTopNews United StatesAnother one in the queue of manufacturing weight loss drug is Orexigen Therapeutics which intends to file for FDA approval by April.Anti-Obesity Drug Qnexa by Vivus


  • Leave a Reply

    Security Code: